ASB Consultores’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
ASB Consultores's LLY Position: Q1 2026 in Review
ASB Consultores opened a new position in Eli Lilly (LLY) in Q1 2026: 270 shares worth $267K. The stake represents 0.89% of the portfolio and ranks #30 among its holdings. This is a return to the name: ASB Consultores previously reported a position in LLY as recently as Q2 2025.
ASB Consultores first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.63M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- ASB Consultores held 270 shares of Eli Lilly worth $267K as of Q1 2026.
- Eli Lilly was a new ASB Consultores position in Q1 2026.
- Eli Lilly made up 0.89% of ASB Consultores's portfolio in Q1 2026, its #30 holding.
- ASB Consultores first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
- ASB Consultores's Eli Lilly position peaked at $1.63M in Q1 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on ASB Consultores's 13F filing for Q1 2026, filed 15 May 2026.